Gene-editing tool CRISPR may soon be used to treat humans for the first time

The controversial gene-editing tool CRISPR may soon be used to create custom blood cells that hunt cancer — its first use to treathumans. A study at the University of Pennsylvaniareceived an initial approval from the ethical gatekeepers at the National Institutes of Health this week, the government body's Recombinant DNA Advisory Committee (RAC) signing off on its potential use in a human trial.
Immune cells will be edited and then inserted back into cancer patients
The desi